GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response
Authors:
- 1 March 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (5) , 2037-2044
Abstract
Interleukin (IL)-10 and glucocorticoids (GCs) inhibit the ability of antigen-presenting dendritic cells (DCs) to stimulate T lymphocytes. We show that induction of GILZ (GC-induced leucine zipper) is involved in this phenomenon. IL-10, dexamethasone (DEX), and transforming growth factor (TGF)β stimulate GILZ production in human immature DCs derived from monocytes and from CD34+ cells. GILZ is necessary and sufficient for DEX, IL-10, and TGFβ modulation of CD80, CD83, CD86, immunoglobulin-like transcript (ILT)-3, and B7-H1 expression by DCs, and alteration of DC functions. GILZ stimulates the production of IL-10 by immature DCs and prevents the production of inflammatory chemokines by CD40L-activated DCs. In contrast, GILZ does not prevent CD40 ligand-mediated inhibition of phagocytosis, indicating that it affects some but not all aspects of DC maturation. GILZ prevents DCs from activating antigen-specific T lymphocyte responses. Administration of GCs to patients stimulates GILZ expression in their circulating antigen-presenting cells, and this contributes to the weak lymphocyte responses of GC-treated patients. Thus, regulation of GILZ expression is an important factor determining the decision of DCs whether or not to stimulate T lymphocytes, and IL-10, GCs, and TGFβ share this mechanism for influencing DC functions and the balance between immune response and tolerance.Keywords
This publication has 37 references indexed in Scilit:
- Lentiviral transduction of human hematopoietic cells by HIV‐1‐ and SIV‐based vectors containing a bicistronic cassette driven by various internal promotersThe Journal of Gene Medicine, 2005
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- Efficient transduction and selection of human T‐lymphocytes with bicistronic Thy1/HSV1‐TK retroviral vector produced by a human packaging cell lineThe Journal of Gene Medicine, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in VivoJournal of Experimental Medicine, 2001
- Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κBBlood, 2001
- High Level of Retrovirus-Mediated Gene Transfer into Dendritic Cells Derived from Cord Blood and Mobilized Peripheral Blood CD34+ CellsHuman Gene Therapy, 1999
- Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB SynthesisScience, 1995
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by GlucocorticoidsScience, 1995
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992